fomesafen has been researched along with Kahler Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Damoiseaux, JGMC; de Boer, D; Knapen-Portz, YM; Ludwiczek, PK; Ritzen, LFL; Teuwen, JTJ; van Beers, JJBC | 1 |
| Diokno, AC; Koppenhoefer, R | 1 |
2 other study(ies) available for fomesafen and Kahler Disease
| Article | Year |
|---|---|
Identifying therapeutic monoclonal antibodies using target protein collision electrophoresis reflex assay to separate the wheat from the chaff.
Topics: Antibodies, Monoclonal; Electrophoresis; Humans; Immunoelectrophoresis; Multiple Myeloma; Paraproteinemias; Reflex | 2023 |
Bethanechol chloride in neurogenic bladder dysfunction.
Topics: Achondroplasia; Adult; Bethanechol Compounds; Dose-Response Relationship, Drug; Female; Humans; Injections, Subcutaneous; Lumbar Vertebrae; Male; Multiple Myeloma; Muscle Relaxation; Paraplegia; Reflex; Spinal Cord Compression; Spinal Cord Injuries; Spinal Cord Neoplasms; Urinary Bladder, Neurogenic; Urinary Catheterization | 1976 |